0001213900-17-004351.txt : 20170428 0001213900-17-004351.hdr.sgml : 20170428 20170428111658 ACCESSION NUMBER: 0001213900-17-004351 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170428 DATE AS OF CHANGE: 20170428 EFFECTIVENESS DATE: 20170428 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Icagen, Inc. CENTRAL INDEX KEY: 0001518520 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 200982060 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-285706 FILM NUMBER: 17792633 BUSINESS ADDRESS: STREET 1: 4222 EMPEROR BLVD., SUITE 350 STREET 2: RESEARCH TRIANGLE PARK CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-941-5206 MAIL ADDRESS: STREET 1: 4222 EMPEROR BLVD., SUITE 350 STREET 2: RESEARCH TRIANGLE PARK CITY: DURHAM STATE: NC ZIP: 27703 FORMER COMPANY: FORMER CONFORMED NAME: XRpro Sciences, Inc. DATE OF NAME CHANGE: 20141204 FORMER COMPANY: FORMER CONFORMED NAME: Caldera Pharmaceuticals Inc DATE OF NAME CHANGE: 20110419 D 1 primary_doc.xml X0707 D LIVE 0001518520 Icagen, Inc. 4222 EMPEROR BLVD., SUITE 350 RESEARCH TRIANGLE PARK DURHAM NC NORTH CAROLINA 27703 919-941-5206 DELAWARE Caldera Pharmaceuticals, Inc. XRpro Sciences, Inc. Caldera Pharmaceuticals Inc Corporation true Richard Cunningham 4222 EMPEROR BLVD., SUITE 350 RESEARCH TRIANGLE PARK DURHAM NC NORTH CAROLINA 27703 Executive Officer Benjamin Warner 4222 Emperor Blvd., Suite 350 Research Triangle Park Durham NC NORTH CAROLINA 27703 Director Timothy Tyson 4222 Emperor Blvd., Suite 350 Research Triangle Park Durham NC NORTH CAROLINA 27703 Director Michael Taglich 4222 Emperor Blvd., Suite 350 Research Triangle Park Durham NC NORTH CAROLINA 27703 Director Mark Korb 4222 Emperor Blvd., Suite 350 Research Triangle Park Durham NC NORTH CAROLINA 27703 Executive Officer Vincent Palmieri 4222 Emperor Blvd., Suite 350 Durham NC NORTH CAROLINA 27703 Director Clive Kabatznik 4222 Emperor Blvd., Suite 350 Durham NC NORTH CAROLINA 27703 Director Edward Roffman 4222 Emperor Blvd., Suite 350 Durham NC NORTH CAROLINA 27703 Director Douglas Krafte 4222 Emperor Blvd., Suite 350 Durham NC NORTH CAROLINA 27703 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2017-04-12 false true true false 500000 TAGLICH BROTHERS, INC. ("TAGLICH") 29102 None None 275 MADISON AVENUE SUITE 1618 NEW YORK NY NEW YORK 10016 CT CONNECTICUT NY NEW YORK false 1500000 1500000 0 *The amount being raised was a minimum of $1,000,000 true 0 3 60000 true 0 *Designees of Taglich also received a warrant to acquire 25,000 shares of common stock as compensation 0 true *Proceeds may be used to pay overhead and other corporate expenses which could include salaries false Icagen, Inc. /s/ Richard Cunningham Richard Cunningham Chief Executive Officer 2017-04-27